L. Lu

New Insights into Neuroinflammation Involved in Pathogenic Mechanism of Alzheimer’s Disease and Its Potential for Therapeutic Intervention

Bocheng Zhang, Xi-nuo Li, Zheying Zhu, 2022, Cells.

Novel and Potent Acetylcholinesterase Inhibitors for the Treatment of Alzheimer’s Disease from Natural (±)-7,8-Dihydroxy-3-methyl-isochroman-4-one

Pengfei Zhang, Hequan Yao, Jinyi Xu, 2022, Molecules.

Design, synthesis and anticancer properties of isocombretapyridines as potent colchicine binding site inhibitors.

Shengtao Xu, Jinyi Xu, Hong Yao, 2020, European journal of medicinal chemistry.

Synthesis, biological evaluation and mechanism studies of C-23 modified 23-hydroxybetulinic acid derivatives as anticancer agents.

Shengtao Xu, Jinyi Xu, Jie Liu, 2019, European journal of medicinal chemistry.

Discovery of novel hybrids containing clioquinol-1-benzyl-1,2,3,6-tetrahydropyridine as multi-target-directed ligands (MTDLs) against Alzheimer's disease.

Pengfei Zhang, Hequan Yao, Jinyi Xu, 2022, European journal of medicinal chemistry.

Design, Synthesis, and Biological Evaluation of Novel Chromanone Derivatives as Multifunctional Agents for the Treatment of Alzheimer's Disease.

Hequan Yao, Jinyi Xu, Yilin Jia, 2022, ACS chemical neuroscience.

Design and synthesis of NAD(P)H: Quinone oxidoreductase (NQO1)-activated prodrugs of 23-hydroxybetulinic acid with enhanced antitumor properties.

W. Ye, Shengtao Xu, Jinyi Xu, 2022, European journal of medicinal chemistry.

Chemodivergent synthesis of N-(pyridin-2-yl)amides and 3-bromoimidazo[1,2-a]pyridines from α-bromoketones and 2-aminopyridines

Shengtao Xu, Jinyi Xu, Cong Ma, 2019, RSC advances.

Design and synthesis of antagonists of substance P.

K. Folkers, S. Rosell, L. Lu, 1986, Acta chemica Scandinavica. Series B: Organic chemistry and biochemistry.